Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Michal, Gershinsky"'
Autor:
Adnan, Zaina, Ilan, Shimon, Ali, Abid, Eldad, Arad, Elzbieta, Baron, Elena, Golden, Michal, Gershinsky, Nariman, Saba Khazen, Mohammed, Abu Saleh, Noga, Roguin Maor, Orit, Bardicef, Yulia, Pauker, Sameer, Kassem
Publikováno v:
The Israel Medical Association journal : IMAJ. 24(7)
National registries for acromegaly and population-based data make an important contribution to disease understanding and management. Data concerning the epidemiology of acromegaly in Israel is scanty.To evaluate the epidemiology of acromegaly in diff
Autor:
Reut Halperin, Liat Arnon, Sapir Nasirov, Limor Friedensohn, Michal Gershinsky, Alona Telerman, Eitan Friedman, Rinat Bernstein-Molho, Amit Tirosh
Publikováno v:
Endocrine-related cancer.
Multiple endocrine neoplasia 4 (MEN4) is a rare multiglandular endocrine neoplasia syndrome clinically hallmarked by primary hyperparathyroidism (PHPT), pituitary adenoma (PitAd), and neuroendocrine tumors (NET), clinically overlapping MEN1. The unde
Publikováno v:
Thyroid. 29:193-201
Agranulocytosis occurs in 0.2-0.5% of patients treated with the antithyroid drugs (ATDs) methimazole and propylthiouracil. The objectives of this study were to evaluate the risk of ATD-related agranulocytosis in patients with amiodarone-induced thyro
Autor:
Yulia Pauker, Amit Akirov, Ilan Shimon, Michal Gershinsky, Nariman Saba Khazen, Alexander Gorshtein, Idit Dotan
Publikováno v:
Endocrine. 74(2)
Pasireotide long acting (LAR) can be effective in normalizing insulin-like growth factor (IGF)-1 level in acromegaly patients inadequately controlled by octreotide or lanreotide.Determine the long-term efficacy and safety of pasireotide, including ti
Autor:
Ariel Rothner, Yoseph Caraco, Michal Gershinsky, Ehud Arbit, Nariman Saba Khazen, Gregory Burshtein, Phillip Schwartz, Miriam Blum, Sofia Ish-Shalom, William D. Fraser, Auryan Szalat, Jonathan Tang, Arthur Raskin, Hillel Galitzer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fffa736f07297d9eabc02ced82c27c8b
https://doi.org/10.1002/jbmr.4274/v3/response1
https://doi.org/10.1002/jbmr.4274/v3/response1
Autor:
Arthur Raskin, Miriam Blum, Ariel Rothner, Yoseph Caraco, William D. Fraser, Gregory Burshtein, Michal Gershinsky, Nariman Saba Khazen, Ehud Arbit, Hillel Galitzer, Auryan Szalat, Jonathan Tang, Phillip Schwartz, Sofia Ish-Shalom
Publikováno v:
Journal of Bone and Mineral Research
The standard treatment of primary hypoparathyroidism (hypoPT) with oral calcium supplementation and calcitriol (or an analog), intended to control hypocalcemia and hyperphosphatemia and avoid hypercalciuria, remains challenging for both patients and
Publikováno v:
Endocrine Abstracts.
Autor:
Yulia Pauker, Ilan Shimon, Nariman Saba Khazen, Mark J Niven, Zaina Adnan, Carmela Shechner, Lior Baraf, Ali Abid, Alexander Gorshtein, Yona Greenman, Michal Gershinsky
Publikováno v:
Endocrine. 62(2)
Pasireotide, a multi-somatostatin receptor (SSTR)-ligand with high affinity for SSTR5 was recently approved for acromegaly treatment. A retrospective multicenter study investigating the efficacy and safety of long-acting (LAR) pasireotide treatment i
Publikováno v:
Medical & Biological Engineering & Computing. 49:1311-1320
To detect and quantify consistent ECG amplitude changes, the "ECG variability contour" (EVC) method was proposed. Using this method we investigated amplitude changes in subjects undergoing myocardial perfusion imaging (MPI) with Dipyridamole (Dp). Fi
Autor:
Yulia Pauker, Carlos Benbassat, Orit Bardicef, Gloria Tsvetov, Odile Cohen-Ouaqnine, Liat Rot, Yoel Toledano, Zaina Adnan, Jacob Ilany, Sophia Orlovsky, Hadassah Guttmann, David Olchovsky, Ilan Shimon, Yona Greenman, Ofa Makhoul, Rosane Ness-Abramof, Achia Eliash, Mazal Sapir, Michal Gershinsky
Publikováno v:
Pituitary. 12:285-293
We investigated the effectiveness of lanreotide for the treatment of active acromegaly in a retrospectively multicenter case series including 53 patients (24 male, 29 female; mean age at diagnosis, 49.5 +/- 13.9 years) with acromegaly treated with la